Piracetam for Treatment of Cocaine Addiction, Phase II - 4

NCT00000199 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2017-03-30

No results posted yet for this study

Summary

The purpose of this study is to follow patients in Phase I of an inpatient study in an eight week open label assessment of piracetam in an outpatient treatment program.

Conditions

  • Cocaine-Related Disorders

Interventions

DRUG

Piracetam

Sponsors & Collaborators

Principal Investigators

  • Kyle Kampman, M.D. · University of Pennsylvania

Study Design

Purpose
TREATMENT

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000199 on ClinicalTrials.gov